Evidence map›Paper›PMID 41322936›Full record

ReviewCureus2025

Strategies and Recent Advances in Tackling Antibacterial Resistance in India: A Comprehensive Narrative Review.

Tanmay Goudar, Shreyas Desai, Manjunatha Basappa

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tanmay GoudarCollege of Medicine, Mysore Medical College and Research Institute, Mysore, IND.
Shreyas DesaiResearch, Owen J Roberts High School, Pottstown, USA.
Manjunatha BasappaForensic Medicine and Toxicology, JSS Medical College, JSS Academy of Higher Education Research, Mysore, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibacterial resistance (ABR) in India has emerged as a critical public health challenge. Increasing resistance to key antibiotics, including fluoroquinolones and carbapenems, in prevalent pathogens is driven by several factors. This review aims to summarize (1) the mechanisms of action of antibiotics and the emergence of resistance in India, (2) the multifactorial drivers of ABR across human, animal, and environmental sectors, and (3) public health strategic insights based on historical and contemporary literature to provide a roadmap for future interventions. A literature search was conducted using various keywords and databases such as PubMed, Scopus, and Google. Articles published between 1977 and 2025 were retrieved and reviewed. Additional data were integrated from national healthcare strategies and the Indian Priority Pathogens List. Over 200 articles were analyzed to understand the mechanisms of action of antibiotics, the evolution of resistance patterns, the underlying drivers, and the effectiveness of current policies and interventions.  The analysis revealed alarmingly high resistance rates, particularly among gram-negative bacteria such as

Indexed as

antibacterial resistanceantibioticsfactors influencing antibacterial resistanceindiaself-medicationstrategies to overcome antibacterial resistance

Identifiers

PMID41322936
PMCPMC12659878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.